Cancer charity sees success re-prioritizing industry's shelved compounds.
Asher
A
Mullard
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002608:Charities / Q000379:methods* / Q000639:trends; D055808:Drug Discovery / Q000379:methods* / Q000639:trends; D004345:Drug Industry / Q000379:methods* / Q000639:trends; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000453:epidemiology; D006113:United Kingdom
D000970:Antineoplastic Agents